Literature DB >> 2928308

Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line.

H Rubin1, K Xu.   

Abstract

The NIH 3T3 mouse cell line is widely used as a recipient of DNA from tumors to demonstrate the presence of transforming oncogenes. We show that these cells produce transformed foci spontaneously if kept in the confluent state for more than 10 days. The formation of foci depends on the type and concentration of bovine serum used in the medium and passage history of the cells. Cells maintained in continuous exponential multiplication in the subconfluent state by transfer every 2-3 days in medium with 10% calf serum failed to develop the capacity to produce foci in 2% calf serum, but those transferred the same way in 2% calf serum or in 10% fetal bovine serum, which is a less potent growth stimulant, did develop that capacity to an increasing degree over time. The number of transformed cells increased sharply with the time that a culture remained in the confluent state. There are several morphological types and degrees of transformation, which indicates that the underlying changes are varied and the process is progressive. The results also suggest that transformation occurs in a fraction of an entire cell population that is undergoing a physiological adaptation to moderate constraints on its growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2928308      PMCID: PMC286804          DOI: 10.1073/pnas.86.6.1860

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Production of malignancy in vitro. XII. Further transformations of mouse fibroblasts to sarcomatous cells.

Authors:  K K SANFORD; W R EARLE; E SHELTON; E L SCHILLING; E M DUCHESNE; G D LIKELY; M M BECKER
Journal:  J Natl Cancer Inst       Date:  1950-10       Impact factor: 13.506

2.  Uniqueness of each spontaneous transformant from a clone of BALB/c 3T3 cells.

Authors:  H Rubin
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

3.  A quest for the mechanism of "spontaneous" malignant transformation in culture with associated advances in culture technology.

Authors:  K K Sanford; V J Evans
Journal:  J Natl Cancer Inst       Date:  1982-06       Impact factor: 13.506

4.  Quantitative neoplastic transformation of C3H/10T1/2 fibroblasts: dependence upon the size of the initiated cell colony at confluence.

Authors:  L J Mordan; J E Martner; J S Bertram
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

5.  Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells.

Authors:  A R Kennedy; M Fox; G Murphy; J B Little
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

6.  Improved medium and culture conditions for clonal growth with minimal serum protein and for enhanced serum-free survival of Swiss 3T3 cells.

Authors:  G D Shipley; R G Ham
Journal:  In Vitro       Date:  1981-08

7.  Morphology and serum dependence of cloned cell lines undergoing spontaneous malignant transformation in culture.

Authors:  K K Sanford; S L Handleman; G M Jones
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

8.  Early origin and pervasiveness of cellular heterogeneity in some malignant transformations.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

10.  Cell density dependence of focus formation in the C3H/10T1/2 transformation assay.

Authors:  D A Haber; D A Fox; W S Dynan; W G Thilly
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

View more
  36 in total

1.  Coculturing diverse clonal populations prevents the early-stage neoplastic progression that occurs in the separate clones.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Clonal dynamics of progressive neoplastic transformation.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 3.  The significance of biological heterogeneity.

Authors:  H Rubin
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

4.  The cellular ecology of progressive neoplastic transformation: a clonal analysis.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Degrees and kinds of selection in spontaneous neoplastic transformation: an operational analysis.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

6.  Physiological induction and reversal of focus formation and tumorigenicity in NIH 3T3 cells.

Authors:  A L Rubin; P Arnstein; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Growth in high serum concentrations leads to rapid deadaptation of cells previously adapted to growth in an extremely low concentration of serum.

Authors:  A Yao; W Huang; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

8.  Relation of spontaneous transformation in cell culture to adaptive growth and clonal heterogeneity.

Authors:  A L Rubin; A Yao; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

9.  Dynamics of cell transformation in culture and its significance for tumor development in animals.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

10.  Neoplastic development: paradoxical relation between impaired cell growth at low population density and excessive growth at high density.

Authors:  H Rubin; A Yao; M Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.